Clinical Laserthermia Systems AB — Investor Relations & Filings

Clinical Laserthermia Systems (CLS) is a medical technology company that develops and commercializes minimally invasive, image-guided systems for laser ablation. The company's core product is the TRANBERG® Thermal Therapy System, an integrated platform that includes a mobile laser unit, the Thermoguide™ Workstation for real-time monitoring, and sterile, single-use instruments. This system is designed for the precise thermal destruction of diseased tissue, such as tumors, using laser energy. Key clinical applications include neurosurgery for treating brain lesions and urology for the focal therapy of localized prostate cancer. CLS is also advancing immunostimulating laser ablation, a therapy intended to not only destroy the targeted tumor but also to activate the patient's immune system to attack cancer cells systemically.